Obesity and Cardiac diseases

Obesity is a major contributor to the prevalence of cardiovascular disease in the developed world, and same level of attention as other risk factors of coronary artery disease. It is a chronic metabolic disorder associated with cardiovascular disease and increased morbidity and mortality. It implicates a corresponding increase in the number of individuals afflicted with the metabolic syndrome, which defines the obese patient as being "at risk.", by modifying lipids, decreasing blood pressure, and decreasing levels of glycaemia, proinflammatory cytokines, and adhesion molecules, weight loss may prevent the progression of atherosclerosis or the occurrence of acute coronary syndrome events in the obese high-risk population.

  • Obesity and Heart Failure
  • Atrial fibrillation
  • Ischaemic Heart Disease
  • Obstructive Sleep Apnea
  • Systolic and diastolic dysfunction
  • Dyslipidaemia

Related Conference of Obesity and Cardiac diseases

October 20-21, 2025

39th World Congress on Heart Diseases

Frankfurt, Germany
November 13-14, 2025

6th Global Summit on Heart Congress

Paris, France
November 19-20, 2025

7th World Heart Congress

Tokyo, Japan
November 24-25, 2025

36th Annual Cardiologists Conference

Barcelona, Spain
November 27-28, 2025

32nd World Heartcare Summit

Paris, France
January 12-13, 2026

12th International Heart Conference

Dubai, UAE
March 18-19, 2026

15th World Heart Congress

Paris, France
March 23-24, 2026

41st World Cardiology Conference

London, UK
April 08-29, 2026

9th Annual Heart Rhythm Conference

Vienna, Austria
April 13-14, 2026

9th World Heart and Brain Conference

Tokyo, Japan
May 14-15, 2026

5th International Conference on Cardiology

Rome, Italy
May 21-22, 2026

15th World Congress on Cardiology

London, UK
July 29-30, 2026

30th World Cardiology Conference

Paris, France

Obesity and Cardiac diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in